CH633291A5 - Verfahren zur herstellung von pyrimido(1,2-a)benzimidazolderivaten. - Google Patents

Verfahren zur herstellung von pyrimido(1,2-a)benzimidazolderivaten. Download PDF

Info

Publication number
CH633291A5
CH633291A5 CH1507777A CH1507777A CH633291A5 CH 633291 A5 CH633291 A5 CH 633291A5 CH 1507777 A CH1507777 A CH 1507777A CH 1507777 A CH1507777 A CH 1507777A CH 633291 A5 CH633291 A5 CH 633291A5
Authority
CH
Switzerland
Prior art keywords
radical
carbon atoms
formula
hydrogen
mixture
Prior art date
Application number
CH1507777A
Other languages
German (de)
English (en)
Inventor
Stuart Dennett Mills
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB51426/76A external-priority patent/GB1585965A/en
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of CH633291A5 publication Critical patent/CH633291A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CH1507777A 1976-12-09 1977-12-08 Verfahren zur herstellung von pyrimido(1,2-a)benzimidazolderivaten. CH633291A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB51426/76A GB1585965A (en) 1976-12-09 1976-12-09 3,4-dihydropyrimido (1,2 - )benzimidazol - 2(1h) - ones
GB3334177 1977-08-09

Publications (1)

Publication Number Publication Date
CH633291A5 true CH633291A5 (de) 1982-11-30

Family

ID=26261828

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1507777A CH633291A5 (de) 1976-12-09 1977-12-08 Verfahren zur herstellung von pyrimido(1,2-a)benzimidazolderivaten.

Country Status (23)

Country Link
US (1) US4167569A (US07922777-20110412-C00004.png)
JP (1) JPS5390296A (US07922777-20110412-C00004.png)
AT (1) AT359068B (US07922777-20110412-C00004.png)
AU (1) AU514427B2 (US07922777-20110412-C00004.png)
CA (1) CA1086727A (US07922777-20110412-C00004.png)
CH (1) CH633291A5 (US07922777-20110412-C00004.png)
CS (1) CS199696B2 (US07922777-20110412-C00004.png)
DD (1) DD133330A5 (US07922777-20110412-C00004.png)
DE (1) DE2754930A1 (US07922777-20110412-C00004.png)
ES (1) ES464862A1 (US07922777-20110412-C00004.png)
FI (1) FI63577C (US07922777-20110412-C00004.png)
FR (1) FR2373543A1 (US07922777-20110412-C00004.png)
GR (1) GR65298B (US07922777-20110412-C00004.png)
HU (1) HU176540B (US07922777-20110412-C00004.png)
IE (1) IE45924B1 (US07922777-20110412-C00004.png)
IL (1) IL53507A (US07922777-20110412-C00004.png)
IT (1) IT1143729B (US07922777-20110412-C00004.png)
NL (1) NL7713658A (US07922777-20110412-C00004.png)
NO (1) NO774216L (US07922777-20110412-C00004.png)
NZ (1) NZ185823A (US07922777-20110412-C00004.png)
PL (1) PL107142B1 (US07922777-20110412-C00004.png)
SE (1) SE435385B (US07922777-20110412-C00004.png)
SU (1) SU843751A3 (US07922777-20110412-C00004.png)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1157858A (en) 1979-12-03 1983-11-29 Ikuo Ueda Quinazoline derivatives
IE51802B1 (en) * 1979-12-03 1987-04-01 Fujisawa Pharmaceutical Co Quinazoline derivatives,processes for their preparation and pharmaceutical compositions containing them
DE3208218A1 (de) * 1982-03-06 1983-09-08 Basf Ag, 6700 Ludwigshafen Isoindolinfarbstoffe und deren verwendung
RU2453312C1 (ru) * 2010-11-10 2012-06-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" Средство, проявляющее антиагрегантную и антитромбогенную активности
SG11201408617PA (en) 2012-06-27 2015-01-29 4Sc Discovery Gmbh Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and cns disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468888A (en) * 1967-04-11 1969-09-23 Smithkline Corp 2-substituted pyrimido(1,2-a) benzimidazoles
US3988340A (en) * 1975-01-23 1976-10-26 Bristol-Myers Company 6-Alkoxymethyl-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-ones and 7-alkoxymethyl-6-[H]-1,2,3,4-tetrahydropyrimido[2,1-b]quinazolin-2-ones
US4072679A (en) * 1976-06-15 1978-02-07 E. R. Squibb & Sons, Inc. 1,4- AND 4,10-DIHYDRO-4-OXO-PYRIMIDO (1,2-A)-benzimidazole-3-carboxylic acids, esters and amides

Also Published As

Publication number Publication date
CA1086727A (en) 1980-09-30
NZ185823A (en) 1980-08-26
HU176540B (en) 1981-03-28
IL53507A0 (en) 1978-03-10
CS199696B2 (en) 1980-07-31
AU3112177A (en) 1979-06-07
FR2373543B1 (US07922777-20110412-C00004.png) 1980-05-16
DE2754930A1 (de) 1978-06-15
ATA883677A (de) 1980-03-15
SE435385B (sv) 1984-09-24
IE45924B1 (en) 1982-12-29
GR65298B (en) 1980-08-01
PL202753A1 (pl) 1978-10-09
FR2373543A1 (fr) 1978-07-07
US4167569A (en) 1979-09-11
JPS5390296A (en) 1978-08-08
PL107142B1 (pl) 1980-01-31
FI63577C (fi) 1983-07-11
IE45924L (en) 1978-06-09
FI63577B (fi) 1983-03-31
IT1143729B (it) 1986-10-22
FI773724A (fi) 1978-06-10
DD133330A5 (de) 1978-12-27
AT359068B (de) 1980-10-27
AU514427B2 (en) 1981-02-12
IL53507A (en) 1981-07-31
ES464862A1 (es) 1979-01-01
NL7713658A (nl) 1978-06-13
SE7713958L (sv) 1978-06-10
SU843751A3 (ru) 1981-06-30
NO774216L (no) 1978-06-12

Similar Documents

Publication Publication Date Title
EP0682027B1 (de) Pyrrolopyrimidinderivate mit antiproliferativer Wirkung
DE3724164A1 (de) Neue 1,4-benzodiazepine, ihre herstellung und verwendung
DE60207759T2 (de) Pyrimidotriazine als phosphataseinhibitoren
DE69533194T2 (de) PYRAZOLO(3,4-g)CHINOXALINE ALS PDGF-REZEPTOR PROTEIN TYROSIN-KINASE INHIBITOREN
EP0053767B1 (de) Tricyclische Cytosinderivate zur Verwendung in Arzneimitteln und Verfahren zu ihrer Herstellung
DE3413489C2 (US07922777-20110412-C00004.png)
DD266355A5 (de) Verfahren zur herstellung von neuen 1,4-benzodiozepinen
CH633291A5 (de) Verfahren zur herstellung von pyrimido(1,2-a)benzimidazolderivaten.
DE1795022B2 (US07922777-20110412-C00004.png)
DE3447003C2 (de) 7-Acylamino-9a-methoxymitosane, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel
DE3786865T2 (de) Aminosäurederivate enthaltende antikonvulsive Zusammensetzungen und Verwendung dieser Aminosäurederivate.
CH500984A (de) Verfahren zur Herstellung neuartiger Benzomorphan-Derivate
DE1927759A1 (de) Neue basische Derivate des Benzoxazolin-2-ons und Verfahren zur Herstellung derselben
AT394724B (de) Verfahren zur herstellung von n7-amidino-substituierten mitomycin-c-derivaten
DD244556A5 (de) Verfahren zur herstellung von (-)-1beta-aethyl-1alpha-(hydroxymethyl)-1,2,3,4,6,7,12,12b alpha-octahydro-indolo(2,3-a)chinolisin
CH634845A5 (en) Pharmaceutically useful pyrimido(1,2-a)benzimidazole derivatives and corresponding preparations.
EP0180833A1 (de) 4-Oxo-pyrido[2,3]pyrimidin-Derivate, Verfahren zur deren Herstellung und diese ethaltende Arzneimittel
DE2949395A1 (de) Verwendung von substituierten chinazolinen zur behandlung von hochdruck und bradykardie sowie als kardiotone wirkstoffe
DE2901537C2 (US07922777-20110412-C00004.png)
DE2044666A1 (de) N substituierte Indoldimere
AT325620B (de) Verfahren zur herstellung von neuen triazolothienodiazepinverbindungen und deren säureadditionssalzen
AT359074B (de) Verfahren zur herstellung von neuen pyrimido (1,2-a)benzimidazolderivaten
CH631715A5 (de) Verfahren zur herstellung von isoxazolo-(3,4-d)-pyrimidinen.
GB1585965A (en) 3,4-dihydropyrimido (1,2 - )benzimidazol - 2(1h) - ones
CH635842A5 (en) Process for preparing novel 7H-pyrrolo[3,2-f]quinazoline-1,3-diamines

Legal Events

Date Code Title Description
PL Patent ceased